FDA Alert Confirms Heart and Cancer Risks With Tofacitinib ...Middle East

The FDA has alerted the public to an increased risk of serious heart-related problems and cancer risk associated with the Janus kinase inhibitor tofacitinib (Xeljanz, Xeljanz XR). News Alerts

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Alert Confirms Heart and Cancer Risks With Tofacitinib )

Also on site :

• Hamas agrees to release 10 hostages as Trump says there’s a ‘very good chance’ for ceasefire deal this week
• 1 in custody, no shots fired: Police respond to Gaylord Rockies Resort Center Wednesday
• '80s Country Hitmaker Marks 'Well Deserved' Career Milestone 12 Years After Stroke